Download Now: Essential Medicines

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Essential Medicines Programmes
Sudan
now
Now: Essential Medicines programmes
In 2010 , health expenditures
• The public per capita expenditure is US$ 40,
Now: NDP
• The NDP is increasingly act as a framework for
managing the pharmaceutical sector.
Now: Essential Medicines
• It guides the procurement of medicines in the public
sector, health insurance, donations, and local
medicine production.
• It is part of training programme of graduated
pharmacists.
• Today, both public tender prices and C&F prices for
private sector are publically available in websites.
Now: Public Supply System
• Management system improved significantly
– Computerized system at central
– SOPs and adherence to basic standards in drug
supply management
– Monitoring and evaluation systems,
– Managerial auditing system
• Delivery to states through RDF project
– Branch in each state with 8% less in price;
Now: Health Insurance
– Coverage is only 30% of population;
– Based on essential medicines;
– Patient pay 25% of the treatment cost;
– Branch in each state
Now: Health Partners
• Obtaining health partners and donors support to
expand the drug supply & management
component;
– GF delivering free medicines for the TB, HIV and
Malaria
– programmes for control neglected and communicable
diseases e.g Meningitis outbreaks,
– EPI,
– RH
• EHA, in areas where the Government is not
available
Now: Availability
• In 2007, the availability essential medicines in public
sector was 86% and 95% in private sector
• In 2010, availability of essential medicines at public
sector was 80.6%, and in private sector was 93.0%
In 2007, only 67 % are affordable.
Now: RUM
• In 2007; 73% of prescribed medicines in public
sector were from the EML,
• 45% were prescribed by generic name
Now: Regulations essential medicines
• In 2007, independent MRA was established
and Policies separated from regulations;
• With support of WHO/EC roadmap for QC PQ
is in place since 2008.
• Pharmaco-vigilance unit established in 2009;
• Being Uppsala member supported by EC
Other changes
• WHO Good Governance started in 2010
• Pharmaceutical Country Profile, in 2010
• Global Fund Project for 5-years support
• Licensed pharmacists was 1.53/10,000
compared to 0.5/10,000 in 1990,
• HR mapping was conducted
– framework for HRD developed;
Challenges
1. Fragmented health system, with inequitable distribution of
resources;
–
Verticality of supplies by different programme
2. Instability of policies towards public supply system;
3. Poor data and information management system;
4. Efficacy and quality, yet is a question;
5. Distribution and delivery at state level;
6. Accessibility is still low;
7. Low coverage of health insurance;
8. Irrational use of medicines (36% of health expenditures);
9. Capacities to adsorb all available budgets is limited;
10. Policies implementation and monitoring
Thank you